Edition:
United Kingdom

Seattle Genetics Inc (SGEN.OQ)

SGEN.OQ on NASDAQ Stock Exchange Global Select Market

60.48USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$60.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
323,766
52-wk High
$84.35
52-wk Low
$47.79

Chart for

About

Seattle Genetics, Inc. is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer. The Company is engaged in the development and sale of pharmaceutical products on its own behalf or in collaboration with others. The Company's marketed product ADCETRIS, or brentuximab... (more)

Overall

Beta: 2.38
Market Cap(Mil.): $8,225.50
Shares Outstanding(Mil.): 143.03
Dividend: --
Yield (%): --

Financials

  SGEN.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.43 -- --
ROI: -29.99 9.01 14.96
ROE: -32.73 10.15 16.52

Earnings vs. Estimates